July 22, 2013
KARLSRUHE, Germany –– Bruker today announces a standardized nuclear magnetic resonance (NMR) spectroscopy platform for its clinical and diagnostics partners that enables cost-effective, high-performance NMR clinical screening and IVD-by-NMR discovery, development and validation of novel NMR assays. The new AVANCE-IVDr system, presently for research use only, is a complete, proven and standardized platform for NMR [...]
Urine-based Cancer Detection Technology Validated
July 22, 2013
SAN DIEGO, -- Trovagene, Inc. (NASDAQ: TROV) announces that results emerging from ongoing clinical studies have confirmed the broad applicability of Trovagene technology across a variety of cancer types, and the successful development of a molecular diagnostic test capable of detecting and quantifying oncogene mutations from a simple urine specimen. The ability to regularly detect [...]
July 22, 2013
Cambridgeshire, UK ,-- Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial market, and Promega, a leader in providing innovative solutions and technical support to the life sciences industry, have signed a supply agreement for the use of Promega's Ultra-Glo™ luciferase in Lumora's BART (Bioluminescent Assay in Real-Time) molecular diagnostics technology. [...]
Measure Molecular Size of Proteins & Polymers
July 22, 2013
RheoSense, Inc. announces another measurement capability to its unrivalled flagship viscometer, m-VROC. The m-VROC is now equipped with the highest resolution to detect and measure Intrinsic Viscosity, a capability indispensable for all bio/pharma and polymer applications. Intrinsic Viscosity is a parameter used to determine the molecular size, weight, structure, and interactions among proteins, polymers, or [...]
Luminex Corporation Achieves Milestone, Ships 10,000th Instrument
July 22, 2013
AUSTIN, Texas, -- Luminex Corporation (NASDAQ: LMNX) today announced it has passed a major milestone by shipping its 10,000th multiplexing instrument. This milestone was achieved by shipping a MAGPIX® instrument to Dr. Kimberle Chapin at the Rhode Island Hospital in Providence, R.I., the largest hospital and only Level I trauma center in the state. This [...]
July 22, 2013
SDIX, Inc., is now Special Diversified Opportunities, Inc. The Antibody Life Sciences division is now SDIX, LLC. About SDIX SDIX (www.sdix.com) is a biotechnology company with a core expertise in creating better antigens, better antibodies and better assays for the pharmaceutical and biotechnology markets. For over 20 years, SDIX has been a leading immuno-solutions company, [...]
Seegene develops novel real-time array technology for Point of Care Testing (POCT)
July 22, 2013
Gaithersburg, Maryland and SEOUL, Korea,- Seegene Inc., (096530.KQ), a leading developer of multiplex molecular diagnostic technologies and tests, today announced a novel real-time array technology designed specifically to accelerate the development of Point of Care Testing (POCT). The novel real-time array technology successfully eliminates burdensome, time-consuming steps that normally follow PCR amplification and that are [...]
AMSBIO MagSi-DNA cleanFIX Offers Solution for Purifying DNA Fragments
July 22, 2013
MagSi-DNA cleanFIX from AMSBIO offers a cost effective solution for purifying DNA fragments, removing all unwanted side products and reagents, such as single nucleotides, terminator dyes, primers and primer dimers, enzymes, buffers and salts. In many genomics applications, purification of DNA fragments is required to prevent downstream interference with analysis methods. Purification of PCR reactions [...]
Shining the Light on Oligonucleotide Labelling
July 22, 2013
BELLSHILL, SCOTLAND,: Link Technologies Ltd, a specialist oligonucleotide reagent manufacturer, has used its 25 years of industry experience to produce the 2013/14 Product Guide, providing scientists with a wealth of application-orientated content for oligonucleotide chemistry. For easy navigation, the guide is broken into key topics and processes, including Oligonucleotide Labelling Strategies, and each section is [...]
HistoGenetics Selects Illumina’s MiSeq® System as Next-Generation Sequencing Platform of Choice
July 22, 2013
SAN DIEGO & NEW YORK -- Illumina, Inc. (NASDAQ:ILMN) today announced that HistoGenetics, the leader in high-resolution sequence-based human leukocyte antigen (HLA) testing services, has selected the MiSeq sequencing system for use in its CLIA laboratory. HistoGenetics will deploy multiple MiSeqs to supplement its existing Sanger sequencing workflow to sequence HLA genes with high accuracy [...]

